The system has an open architectural design to allow for third-party integrations.
Siemens Healthineers has announced that the FDA has cleared their latest installment of the ARTIS angiography system: ARTIS icono ceiling.
The ceiling-mounted system is designed for a range of interventional radiology and cardiology procedures as well as surgical procedures.
Enhancements to the system's C-arm allows for greater rotational capabilities and simplified cabling leading to cone beam CT acquisitions in 2.5 seconds at the head and 4 seconds at the right and left side of a patient's body. The short spin time both reduces motion artifacts and requires use of less contrast media.
“With the ARTIS icono ceiling, Siemens Healthineers combines excellent image quality and a previously unseen level of design flexibility to be the angiography system of choice for an unprecedented number of interventional radiology and cardiovascular procedures,” said Kris McVey, Vice President of Interventional Radiology and Cardiology at Siemens Healthineers North America, in a statement.
In addition, the system includes predefined Case Flow settings which can help improve overall efficiency and drive standardization within a health system. Benefits of the case flow settings include faster positioning and reduced patient radiation dose. Incorporation of the OPTIQ image chain also helps reduce patient dose while maintaining image quality, with the ARTIS system able to acquire and display images instantly with no loss in image quality.
Lastly, the open-architecture system allows for vendor-neutral integrations.
The ARTIS icono ceiling joins the ARTIS icono biplane and floor systems, which include capabilities with specific advantages for stroke treament and those with budget and space constraints, respectively.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.